The prognostic value of [18F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteria.

Purpose : To investigate the prognostic value of [18F]FDG PET/CT as part of response monitoring in metastatic melanoma patients treated with immune checkpoint inhibitors (ICIs). Methods: Sixty-seven patients underwent [18F]FDG PET/CT before start of treatment (baseline PET/CT), after two cycles (int...

Full description

Bibliographic Details

Published in:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 50; no. 9; pp. 2699 - 2715
Main Authors:	Sachpekidis, Christos, Weru, Vivienn, Kopp-Schneider, Annette, Hassel, Jessica C., Dimitrakopoulou-Strauss, Antonia
Format:	Journal Article
Published:	Springer Nature Jul2023
Online Access:	View this record in EBSCOhost